RESEARCH!AMERICA

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2011–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	4	2
2025	—	8	2
2024	—	8	2
2023	—	12	2
2022	—	8	2
2021	—	9	2
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	7	2
2015	—	9	2
2014	—	4	1
2013	—	5	1
2012	—	4	1
2011	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
RED MAPLE CONSULTING, LLC	—	33
KOUNTOUPES DENHAM CARR & REID, LLC	—	17
KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)	—	24
HOGAN LOVELLS US LLP	—	22

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	72
SENATE	72
Health & Human Services, Dept of (HHS)	7
Agency for Healthcare Research & Quality (AHRQ)	4
Executive Office of the President (EOP)	3
Centers For Disease Control & Prevention (CDC)	1
Natl Institutes of Health (NIH)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	47
Budget/Appropriations	Budget/Appropriations	44
Science/Technology	Science/Technology	23
Veterans	Veterans	4
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	3

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1968119th Congress

Full-Year Continuing Appropriations and Extensions Act, 2025

2025 · first_quarter · Firm: KOUNTOUPES DENHAM CARR & REID, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 1968

H.R. 2225117th Congress

National Science Foundation for the Future Act

2022 · first_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D; Bills: S1260 - United States Innovation and Competition Act of 2021 and HR2225 National Science Foundation for the Future Act; Issues regarding Budget Reconciliation and appropriations funding for science and technology.

Client expense: — · Firm income: $40,000

Matched citations: HR2225

S. 1260117th Congress

United States Innovation and Competition Act of 2021

2022 · first_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D; Bills: S1260 - United States Innovation and Competition Act of 2021 and HR2225 National Science Foundation for the Future Act; Issues regarding Budget Reconciliation and appropriations funding for science and technology.

Client expense: — · Firm income: $40,000

Matched citations: S1260

H.R. 2225117th Congress

National Science Foundation for the Future Act

2021 · fourth_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation and appropriations funding for science and technology.

Client expense: — · Firm income: $30,000

Matched citations: HR 2225

Show 21 more cited filings

S. 1260117th Congress

United States Innovation and Competition Act of 2021

2021 · fourth_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation and appropriations funding for science and technology.

Client expense: — · Firm income: $30,000

Matched citations: S 1260

H.R. 2225117th Congress

National Science Foundation for the Future Act

2021 · third_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation.

Client expense: — · Firm income: $20,000

Matched citations: HR 2225

S. 1260117th Congress

United States Innovation and Competition Act of 2021

2021 · third_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation.

Client expense: — · Firm income: $20,000

Matched citations: S 1260

H.R. 2225117th Congress

National Science Foundation for the Future Act

2021 · third_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation.

Client expense: — · Firm income: $20,000

Matched citations: HR 2225

S. 1260117th Congress

United States Innovation and Competition Act of 2021

2021 · third_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation.

Client expense: — · Firm income: $20,000

Matched citations: S 1260

H.R. 2225117th Congress

National Science Foundation for the Future Act

2021 · third_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation.

Client expense: — · Firm income: $20,000

Matched citations: HR 2225

S. 1260117th Congress

United States Innovation and Competition Act of 2021

2021 · third_quarter · Firm: KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)

Open original LDA filing ↗

Cited source text and reported amounts

Funding for Science and R&D bills; S 1260 - United States Innovation and Competition Act of 2021; HR 2225 - National Science Foundation for the Future Act; Issues regarding budget reconciliation.

Client expense: — · Firm income: $20,000

Matched citations: S 1260

H.R. 1319117th Congress

American Rescue Plan Act of 2021

2021 · first_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Monitor legislation and regulations relating to basic scientific research, particularly as it relates to health care HR 1319, American Rescue Plan Draft infrastructure legislation

Client expense: — · Firm income: $30,000

Matched citations: HR 1319

S. 962117th Congress

American Cures Act

2021 · first_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Monitor legislation and regulations relating to basic scientific research, particularly as it relates to health care S 962

Client expense: — · Firm income: $30,000

Matched citations: S 962

H.R. 1158116th Congress

Consolidated Appropriations Act, 2020

2019 · fourth_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research and basic scientific research, specifically for HR 1158 and HR 1865--consolidated appropriations acts Labor-HHS appropriations bill (NIH, CDC, AHRQ) Agriculture appropriations bill (FDA) Commerce, Justice-Science appropriations bill (NSF)

Client expense: — · Firm income: $30,000

Matched citations: HR 1158

H.R. 1865116th Congress

Further Consolidated Appropriations Act, 2020

2019 · fourth_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research and basic scientific research, specifically for HR 1158 and HR 1865--consolidated appropriations acts Labor-HHS appropriations bill (NIH, CDC, AHRQ) Agriculture appropriations bill (FDA) Commerce, Justice-Science appropriations bill (NSF)

Client expense: — · Firm income: $30,000

Matched citations: HR 1865

H.R. 2470116th Congress

Clean Water Infrastructure Resilience and Sustainability Act

2019 · third_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research and basic scientific research, specifically for HR 2470 and draft Senate FY20 Labor-HHS appropriations bill (NIH, CDC, AHRQ) H.R. 3164 and S. 2522 FY19 Agriculture appropriations bill (FDA) HR 3055 and S 2584 FY20 Commerce, Justice-Science appropriations bill (NSF)

Client expense: — · Firm income: $30,000

Matched citations: HR 2470

H.R. 3055116th Congress

Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019

2019 · third_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research and basic scientific research, specifically for HR 2470 and draft Senate FY20 Labor-HHS appropriations bill (NIH, CDC, AHRQ) H.R. 3164 and S. 2522 FY19 Agriculture appropriations bill (FDA) HR 3055 and S 2584 FY20 Commerce, Justice-Science appropriations bill (NSF)

Client expense: — · Firm income: $30,000

Matched citations: HR 3055

H.R. 3164116th Congress

Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes.

2019 · third_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research and basic scientific research, specifically for HR 2470 and draft Senate FY20 Labor-HHS appropriations bill (NIH, CDC, AHRQ) H.R. 3164 and S. 2522 FY19 Agriculture appropriations bill (FDA) HR 3055 and S 2584 FY20 Commerce, Justice-Science appropriations bill (NSF)

Client expense: — · Firm income: $30,000

Matched citations: H.R. 3164

S. 2522116th Congress

An original bill making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for the fiscal year ending September 30, 2020, and for other purposes.

2019 · third_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research and basic scientific research, specifically for HR 2470 and draft Senate FY20 Labor-HHS appropriations bill (NIH, CDC, AHRQ) H.R. 3164 and S. 2522 FY19 Agriculture appropriations bill (FDA) HR 3055 and S 2584 FY20 Commerce, Justice-Science appropriations bill (NSF)

Client expense: — · Firm income: $30,000

Matched citations: S. 2522

S. 2584116th Congress

An original bill making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2020, and for other purposes.

2019 · third_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research and basic scientific research, specifically for HR 2470 and draft Senate FY20 Labor-HHS appropriations bill (NIH, CDC, AHRQ) H.R. 3164 and S. 2522 FY19 Agriculture appropriations bill (FDA) HR 3055 and S 2584 FY20 Commerce, Justice-Science appropriations bill (NSF)

Client expense: — · Firm income: $30,000

Matched citations: S 2584

H.R. 2470116th Congress

Clean Water Infrastructure Resilience and Sustainability Act

2019 · second_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research, specifically for HR 2470 FY20 Labor-HHS appropriations bill (NIH, CDC, AHRQ) and FY19 Agriculture appropriations bill (FDA) Federal funding for basic scientific research (NSF) in HR 3055 FY20 Commerce, Justice-Science appropriations bill

Client expense: — · Firm income: $30,000

Matched citations: HR 2470

H.R. 3055116th Congress

Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019

2019 · second_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Draft FY20 budget resolution--FY20 caps Federal funding of medical research, specifically for HR 2470 FY20 Labor-HHS appropriations bill (NIH, CDC, AHRQ) and FY19 Agriculture appropriations bill (FDA) Federal funding for basic scientific research (NSF) in HR 3055 FY20 Commerce, Justice-Science appropriations bill

Client expense: — · Firm income: $30,000

Matched citations: HR 3055

H.R. 6421115th Congress

Faster Treatments and Cures for Eye Diseases Act

2018 · fourth_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Monitor committee oversight of scientific research Advocacy for HR 6421, Faster Treatments and Cures for Eye Diseases Act

Client expense: — · Firm income: $30,000

Matched citations: HR 6421

H.R. 1628115th Congress

American Health Care Act of 2017

2018 · first_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Monitor health care reform legislation, specifically Prevention and Public Health Fund in H.R. 1628, American Health Care Act of 2017 Monitor committee oversight of scientific research

Client expense: — · Firm income: $30,000

Matched citations: H.R. 1628

H.R. 1628115th Congress

American Health Care Act of 2017

2017 · fourth_quarter · Firm: RED MAPLE CONSULTING, LLC

Open original LDA filing ↗

Cited source text and reported amounts

Monitor health care reform legislation, specifically Prevention and Public Health Fund in H.R. 1628, American Health Care Act of 2017 Monitor committee oversight of scientific research

Client expense: — · Firm income: $30,000

Matched citations: H.R. 1628

Source: Senate LDA

RESEARCH!AMERICA — Lobbying Disclosure | Poliscope